scholarly journals Management of late onset urea cycle disorders—a remaining challenge for the intensivist?

2021 ◽  
Vol 11 (1) ◽  
Author(s):  
S. Redant ◽  
A. Empain ◽  
A. Mugisha ◽  
P. Kamgang ◽  
R. Attou ◽  
...  

Abstract Background Hyperammonemia caused by a disorder of the urea cycle is a rare cause of metabolic encephalopathy that may be underdiagnosed by the adult intensivists because of its rarity. Urea cycle disorders are autosomal recessive diseases except for ornithine transcarbamylase deficiency (OTCD) that is X-linked. Optimal treatment is crucial to improve prognosis. Main body We systematically reviewed cases reported in the literature on hyperammonemia in adulthood. We used the US National Library of Medicine Pubmed search engine since 2009. The two main causes are ornithine transcarbamylase deficiency followed by type II citrullinemia. Diagnosis by the intensivist remains very challenging therefore delaying treatment and putting patients at risk of fatal cerebral edema. Treatment consists in adapted nutrition, scavenging agents and dialysis. As adults are more susceptible to hyperammonemia, emergent hemodialysis is mandatory before referral to a reference center if ammonia levels are above 200 µmol/l as the risk of cerebral edema is then above 55%. Definitive therapy in urea cycle abnormalities is liver transplantation. Conclusion Awareness of urea cycle disorders in adults intensive care units can optimize early management and accordingly dramatically improve prognosis. By preventing hyperammonemia to induce brain edema and herniation leading to death.

Author(s):  
Brendan Lanpher

The urea cycle is a series of steps required to generate urea from nitrogen produced by protein catabolism. The cycle was first described in 1932 by Krebs and Henseleit (Krebs and Henseleit 1932). Six enzymes and two transporters are necessary for urea cycle activity. Specific deficiencies have been described with each of these. The process converts nitrogen from ammonia and aspartate into urea, which is freely excreted by the kidney (Brusilow 1995). Embedded within the urea cycle is the nitric oxide cycle. Nitric oxide is generated from arginine by nitric oxide synthase (NOS), producing citrulline (Scaglia et al. 2004). The entire urea cycle is present only in the liver. The proximal cycle (N-acetylglutamate synthase [NAGS], carbamyl phosphate synthetase [CPS], ornithine transcarbamylase [OTC]) is also present in the intestinal tract, whereas the distal cycle (argininosuccinic acid synthase [ASS], argininosuccinic acid lyase [ASL], arginase [ARG]) is active in the kidney. The most common of the urea cycle disorders (UCDs) is ornithine transcarbamylase deficiency, which is inherited in an X-linked manner. All of the others are autosomal recessive. The overall incidence of all urea cycle disorders is estimated at between 1/10,000 to 1/25,000, although patients with incomplete deficiency are likely significantly more common (Nagata, Matsuda et al. 1991). When the urea cycle function is absent or diminished, either by direct enzymatic deficiency or by secondary inhibition of the proximal four steps, nitrogen accumulates in the form of toxic ammonium. In null activity patients, this typically presents in the first days of life with hyperammonemia, resulting in central nervous system (CNS) dysfunction with overwhelming encephalopathy and coma, brain edema, seizures, and potentially death, with severe long-term neurodevelopmental sequelae if not rapidly reversed. The differential diagnosis of severe hyperammonemia includes organic acidemias, herpes-related hepatitis, and other disorders of liver function. Respiratory alkalosis and hyperventilation is classically seen in UCDs, although if encephalopathy progresses, apneas and acidosis may be seen (Burton 1998). If not recognized and reversed immediately, this may progress to fatal cerebral edema and herniation. There are multiple postulated mechanisms for ammonia-related neurotoxicity.


2016 ◽  
Vol 04 (01) ◽  
pp. 033-043
Author(s):  
Johannes Häberle ◽  
Véronique Rüfenacht

2020 ◽  
Vol 33 (6) ◽  
pp. 721-728
Author(s):  
Özlem Saritaş Nakip ◽  
Yılmaz Yıldız ◽  
Ayşegül Tokatlı

AbstractObjectivesUrea cycle disorders (UCDs) are rare hereditary diseases. This study was conducted to help identify the characteristics of UCDs in Turkey.MethodsThe primary outcome was to determine patient characteristics. Investigating the relationships between the patient outcomes and ammonia levels were the secondary outcomes. Eighty five patients from 79 families, diagnosed with UCD at a single metabolic referral center between 1979 and 2017, were included. Clinical and laboratory data were retrieved retrospectively from hospital records.ResultsClassical citrullinemia was the most common type of UCD; citrin deficiency and carbamoyl phosphate synthase 1 deficiency (CPS1D) were the rarest. One thirty one hyperammonemic episodes were recorded. The peak ammonia levels were found to be significantly associated with polycythemia and hypocalcemia at presentation. The median peak ammonia values of the patients who died were higher than those of the survivors. The highest mortality rate was in the classical citrullinemia group. The mortality rate of the first hyperammonemic crisis was 28.6%, while it was 6.7% in subsequent episodes with an odds ratio of 4.28 (95% CI: 1.67–11.0) (p=0.001). Forty-four patients underwent genetic analysis and genetic variants were detected in 42 patients (95%). Three of the detected variants have not been previously reported.ConclusionsThis is the largest UCD series in Turkey and may serve as a guide to clinical, biochemical and genetic features of UCDs in our country. Prevention of hyperammonemia may be the most influential measure to improve long term survival.


Author(s):  
Sandesh C.S. Nagamani ◽  
Saima Ali ◽  
Rima Izem ◽  
Deborah Schady ◽  
Prakash Masand ◽  
...  

2019 ◽  
Vol 42 (6) ◽  
pp. 1176-1191 ◽  
Author(s):  
Susan E. Waisbren ◽  
Arianna K. Stefanatos ◽  
Teresa M. Y. Kok ◽  
Burcu Ozturk‐Hismi

Sign in / Sign up

Export Citation Format

Share Document